(S,S)-2-(2-benzylamino-1-hydroxy-ethyl)-6-fluoro-chroman-4-one | 797054-35-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: (S,S)-2-(2-benzylamino-1-hydroxy-ethyl)-6-fluoro-chroman-4-one
• 英文别名: (2S)-2-[(1S)-2-(benzylamino)-1-hydroxyethyl]-6-fluoro-2,3-dihydrochromen-4-one
• CAS: 797054-35-4
• 化学式: C₁₈H₁₈FNO₃
• 分子量: 315.344
• InChiKey: CHEVUKFNOPAQBH-WMZOPIPTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  23
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (R,S)-6-fluoro-2-(oxiran-2-yl)-chromane-4-one 、 (S,S)-2-(2-benzylamino-1-hydroxy-ethyl)-6-fluoro-chroman-4-one 反应 0.25h， 以100%的产率得到N-benzyl-N-[(S,S)-1-hydroxy-2-(6-fluoro-chroman-4-one-2-yl)]-N-[(R,S)-1-hydroxy-2-(6-fluoro-chroman-4-one-2-yl)]-amine
  参考文献：
  名称：

  [EN] NEW PROCESS FOR THE PREPARATION OF RACEMIC ([2S[2R*[R[R*]]]] and ([2R[2S*[S[S*]]]]-(±)- alpha,alpha' -[imino-bis(methylene)]bis[6-fluoro­chroman-2-methanol] AND ITS PURE [2S[2R*[R[R*]&
  [FR] NOUVEAU PROCEDE DE PREPARATION DE ([2S[2R*[R[R*]]]] ET ([2R[2S*[S[S*]]]]-(+/-)- 20040521US4654362AVAN LOMMEN GUY R E [BE], et al198703311528DA1DAJ. HENDRICKX ET AL.: "LOCATION OF THE OH FUNCTIONS IN HYDROXYLATED METABOLITES OF NEBIVOLOL", JOURNAL OF CHROMATOGRAPHY A, vol. 729, no. 1+2, 1996, GB, pages 341 - 354, XP002270638J. HENDRICKX ET AL.LOCATION OF THE OH FUNCTIONS IN HYDROXYLATED METABOLITES OF NEBIVOLOLJOURNAL OF CHROMATOGRAPHY AGB19967291+2341354353VA1,54,55A

  摘要：

  用于制备化合物（I）的混合对映体（[2S[2R*[R[R*]]]]-和([2R[2S*[S[S*]]]]-(±)- α,α' -[亚胺-双(亚甲基)]双[6-氟基-色苷-2-甲醇]的过程及其纯度（[2S[2R*[R[R*]]]]-和([2R[2S*[S[S*]]]]-对映体化合物的特征在于所述产物是从4-氟苯酚或4-氟苯甲醚经过结晶的、具有光学活性的中间体制备而成。

  公开号：

  WO2004041805A1

文献信息

• Process for preparation of racemic Nebivolol
  申请人：Bader Thomas

  公开号：US20070149612A1

  公开（公告）日：2007-06-28

  A process of making racemic [2S*[R*[R*[R*]]]] and [2R*[S*[S*[S*]]]]-(±)α,α′-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] of the compound of the formula (I) and its pure [2S*[R*[R*[R*]]]]- and [2R*[S*[S*[S*]]]]-enantiomer compounds and pharmaceutically acceptable salts thereof.

  将化合物的立体异构体制备成racemic [2S*[R*[R*[R*]]]]和[2R*[S*[S*[S*]]]]-(±)α,α′-[iminobis(methylene)]bis[6-氟-3,4-二氢-2H-1-苯并吡喃-2-甲醇]的过程，以及其纯[2S*[R*[R*[R*]]]]-和[2R*[S*[S*[S*]]]]-对映体化合物及其药用可接受的盐。
• PROCESS FOR PREPARATION OF RACEMIC NEBIVOLOL
  申请人：Bader Thomas

  公开号：US20090048457A1

  公开（公告）日：2009-02-19

  A process of making racemic [2S*[R*[R*[R*]]]] and [2R*[S*[S*[S*]]]]-(±)α,α′-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] of the compound of the formula (I) and its pure [2S*[R*[R*[R*]]]]- and [2R*[S*[S*[S*]]]]-enantiomer compounds and pharmaceutically acceptable salts thereof.

  制备(±)α,α′-[亚氨基双(亚甲基)]双[6-氟-3,4-二氢-2H-1-苯并吡喃-2-甲醇]的外消旋体[2S*[R*[R*[R*]]]]和[2R*[S*[S*[S*]]]]的过程，以及该化合物的纯[2S*[R*[R*[R*]]]]-和[2R*[S*[S*[S*]]]]-对映体化合物及其药学上可接受的盐。
• US7560575B2
  申请人：——

  公开号：US7560575B2

  公开（公告）日：2009-07-14
• [EN] NEW PROCESS FOR THE PREPARATION OF RACEMIC ([2S[2R*[R[R*]]]] and ([2R[2S*[S[S*]]]]-(±)- alpha,alpha' -[imino-bis(methylene)]bis[6-fluoro­chroman-2-methanol] AND ITS PURE [2S[2R*[R[R*]&<br/>[FR] NOUVEAU PROCEDE DE PREPARATION DE ([2S[2R*[R[R*]]]] ET ([2R[2S*[S[S*]]]]-(+/-)- 20040521US4654362AVAN LOMMEN GUY R E [BE], et al198703311528DA1DAJ. HENDRICKX ET AL.: "LOCATION OF THE OH FUNCTIONS IN HYDROXYLATED METABOLITES OF NEBIVOLOL", JOURNAL OF CHROMATOGRAPHY A, vol. 729, no. 1+2, 1996, GB, pages 341 - 354, XP002270638J. HENDRICKX ET AL.LOCATION OF THE OH FUNCTIONS IN HYDROXYLATED METABOLITES OF NEBIVOLOLJOURNAL OF CHROMATOGRAPHY AGB19967291+2341354353VA1,54,55A
  申请人：EGYT GYOGYSZERVEGYESZETI GYAR

  公开号：WO2004041805A1

  公开（公告）日：2004-05-21

  Process for the preparation of racemic ([2S[2R*[R[R*]]]]- and ([2R[2S*[S[S*]]]]-(±)- α,α' -[imino-bis(methylene)]bis[6-fluoro­chroman-2-methanol] of the compound of the formula (I) and its pure ([2S[2R*[R[R*]]]]- and ([2R[2S*[S[S*]]]]- enantiomer compounds characterized in that the products are prepared from 4-­fluoro-phenole or 4-fluoro-anisole via crystalline, optically active intermediates.

  用于制备化合物（I）的混合对映体（[2S[2R*[R[R*]]]]-和([2R[2S*[S[S*]]]]-(±)- α,α' -[亚胺-双(亚甲基)]双[6-氟基-色苷-2-甲醇]的过程及其纯度（[2S[2R*[R[R*]]]]-和([2R[2S*[S[S*]]]]-对映体化合物的特征在于所述产物是从4-氟苯酚或4-氟苯甲醚经过结晶的、具有光学活性的中间体制备而成。